| |
| |
|
| Insider
Information: |
Kelley John P |
| Relationship: |
Chief Executive Office... |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,282,932 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$333,434 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,282,932 |
|
|
| Total
Value |
$333,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Director |
2015-01-13 |
0 |
2013-08-02 |
0 |
Premium* |
|
|
Tenax Therapeutics Inc |
TENX |
Chief Executive Office... |
2017-03-15 |
1,282,932 |
2013-11-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TENX |
Tenax Therapeutics Inc |
Chief Executive Officer |
• • – |
2017-03-15 |
4 |
D |
$0.68 |
$65,959 |
D/D |
(96,999) |
1,282,932 |
0 |
- |
|
| TENX |
Tenax Therapeutics Inc |
Chief Executive Officer |
• • – |
2017-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
213,420 |
1,379,931 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2015-01-13 |
4 |
AS |
$44.00 |
$440,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2015-01-13 |
4 |
OE |
$25.45 |
$254,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2014-12-18 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2014-12-18 |
4 |
OE |
$16.74 |
$167,400 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| TENX |
Tenax Therapeutics Inc |
Chief Executive Officer |
• • – |
2013-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
8,248 |
8,248 |
0 |
- |
|
| TENX |
Tenax Therapeutics Inc |
Chief Executive Officer |
• • – |
2013-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
341,711 |
341,711 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2013-08-02 |
4 |
AS |
$38.00 |
$570,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2013-08-02 |
4 |
OE |
$16.74 |
$251,100 |
D/D |
15,000 |
15,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
